Hemodiafiltration
Springer International Publishing (Verlag)
978-3-319-23331-4 (ISBN)
Menso J. Nubé is professor at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam, the Netherlands. He is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and an expert in cardiovascular disease in patients with kidney disease. Muriel P.C. Grooteman is internist/nephrologist at the department of Nephrology at the VU Vrije Universiteit Medical Center (VUmc) in Amsterdam. She is involved in research on biocompatibility of hemodialysis treatment and hemodiafiltration since 1993, and a specialist in cardiovascular complications of dialysis treatment. Peter J. Blankestijn is internist/nephrologist and associate professor at the department of Nephrology at the University Medical Center Utrecht (UMCU) in Utrecht, the Netherlands. He is an expert in autonomic dysregulation in patients with end stage kidney disease, and involved in research on hemodialysis and hemodiafiltration since the 90s.
Chapter 1 General introduction.- PART I: TECHNICAL ASPECTS.- Chapter 2 Convective techniques.- Chapter 3 Water treatment and safety requirements.- Chapter 4 Description of hemodiafiltration.- Chapter 5 Dialyzers for hemodiafiltration.- PART II: EFFECTS OF HEMODIAFILTRATION ON VARIOUS BIOMARKERS.- Chapter 6 Effects on electrolytes and mineral metabolism.- Chapter 7 Effects on anemia control.- Chapter 8 Effects on inflammation and oxidative stress.- Chapter 9 Effects on the removal of uremic toxins.- Chapter 10 Effects on platelets and coagulation.- PART III: CLINICAL ASPECTS OF HEMODIAFILTRATION.- Chapter 11 Clinical trials on online postdilution hemodiafiltration.- Chapter 12 Cardiovascular effects.- Chapter 13 Hemodynamic stability.- Chapter 14 Nutrition in convective treatments.- Chapter 15 Why is high volume hemodiafiltration associated with improved survival?.- Chapter 16 Hemodiafiltration in children.- Chapter 17 Intensified hemodiafiltration schemes.- Chapter 18 Potential disadvantages of hemodiafiltration.- PART IV: PRACTICAL ISSUES.- Chapter 19 Practical guide to performing high volume hemodiafiltration.- Chapter 20 Medication and hemodiafiltration.- PART V: SUMMARY AND CONCLUSIONS.- Chapter 21 Current status of hemodiafiltration.
"It is designed to introduce hemodiafiltration to healthcare professionals and those involved in the dialysis industry, and to discuss how current dialysis therapies have not provided improved survival benefits to patients. ... It is aimed at healthcare professionals, regulating bodies, the dialysis industry, patients, and the insurance industry. ... This book is very important to modern day nephrology. ... an excellent introduction to the modality, its potential future use in treating the dialysis population, and potential for improved patient survival." (Juan-Carlos Aycnena, Doody's Book Reviews, May, 2016)
Erscheint lt. Verlag | 20.11.2015 |
---|---|
Zusatzinfo | XIV, 348 p. 63 illus., 27 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
Medizinische Fachgebiete ► Innere Medizin ► Nephrologie | |
Schlagworte | Convective Clearance • Hematology • Hemodialfiltration • Hemodialysis • Medicine • Nephrology • Technical Guide • Uremic Clearance |
ISBN-10 | 3-319-23331-9 / 3319233319 |
ISBN-13 | 978-3-319-23331-4 / 9783319233314 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich